- Home
- VTYX vs TROO Comparison
VTYX vs TROO Comparison
Compare VTYX & TROO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTYX
- TROO
- Stock Information
- Founded
- VTYX 2018
- TROO 2005
- Country
- VTYX United States
- TROO Hong Kong
- Employees
- VTYX N/A
- TROO N/A
- Industry
- VTYX Medicinal Chemicals and Botanical Products
- TROO Radio And Television Broadcasting And Communications Equipment
- Sector
- VTYX Health Care
- TROO Technology
- Exchange
- VTYX Nasdaq
- TROO Nasdaq
- Market Cap
- VTYX 184.6M
- TROO 215.4M
- IPO Year
- VTYX 2021
- TROO N/A
- Fundamental
- Price
- VTYX $2.30
- TROO $1.89
- Analyst Decision
- VTYX Buy
- TROO
- Analyst Count
- VTYX 5
- TROO 0
- Target Price
- VTYX $8.40
- TROO N/A
- AVG Volume (30 Days)
- VTYX 2.3M
- TROO 58.2K
- Earning Date
- VTYX 11-07-2024
- TROO 12-31-2024
- Dividend Yield
- VTYX N/A
- TROO N/A
- EPS Growth
- VTYX N/A
- TROO N/A
- EPS
- VTYX N/A
- TROO N/A
- Revenue
- VTYX N/A
- TROO $3,569,000.00
- Revenue This Year
- VTYX N/A
- TROO N/A
- Revenue Next Year
- VTYX N/A
- TROO N/A
- P/E Ratio
- VTYX N/A
- TROO N/A
- Revenue Growth
- VTYX N/A
- TROO N/A
- 52 Week Low
- VTYX $1.67
- TROO $0.73
- 52 Week High
- VTYX $11.48
- TROO $4.89
- Technical
- Relative Strength Index (RSI)
- VTYX 47.68
- TROO 49.05
- Support Level
- VTYX $2.21
- TROO $1.85
- Resistance Level
- VTYX $2.54
- TROO $2.09
- Average True Range (ATR)
- VTYX 0.27
- TROO 0.24
- MACD
- VTYX -0.05
- TROO 0.03
- Stochastic Oscillator
- VTYX 8.02
- TROO 23.86
About VTYX Ventyx Biosciences Inc.
Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders. The company is developing a pipeline of novel small-molecule product candidates to address a range of inflammatory diseases. Its product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.
About TROO TROOPS Inc.
TROOPS Inc is a conglomerate group of various businesses with its headquarters based in Hong Kong. The group is principally engaged in money lending business in Hong Kong providing mortgage loans to high quality target borrowers, property investment to generate additional rental income and the development, operation and management of an online financial marketplace that provides one-stop financial technology solutions including API services by leveraging artificial intelligence, large data and blockchain, and cloud computing (SaaS). It derives revenue from Hong Kong and Australia. Majority of its revenue generates from domestic market.